Targeting individual calpain isoforms for neuroprotection

Experimental Neurology

Volumn 226, Issue 1, 2010, Pages 6-7

  Geddes, James W ^a   Saatman, Kathryn E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPAIN 1; CALPAIN 2; CALPAIN 4; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; PARVOVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

CELL LOSS; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE ACTIVATION; GENE TARGETING; HUMAN; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSIENT ISCHEMIC ATTACK; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; ISOMERISM; PHYSIOLOGY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CALPAIN; HUMANS; ISOMERISM; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RNA, SMALL INTERFERING;

EID: 77957779843     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.07.025     Document Type: Note

References (28)

1. Azam M., Andrabi S.S., Sahr K.E., Kamath L., Kuliopulos A., Chishti A.H. Disruption of the mouse mu-calpain gene reveals an essential role in platelet function. Mol. Cell. Biol. 2001, 21:2213-2220.
2. Bevers M.B., Neumar R.W. Mechanistic role of calpains in postischemic neurodegeneration. J. Cereb. Blood Flow Metab. 2008, 28:655-673.
3. Bevers M.B., Lawrence E., Maronski M., Starr N., Amesquita M., Neumar R.W. Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity. J. Neurochem. 2009, 108:1237-1250.
4. Bevers M.B., Ingleton L.P., Che D., Cole J.T., Li L., Da T., Kopil C.M., Cohen A.S., Neumar R.W. RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia. Exp. Neurol. 2010, 224:170-177.
5. Cao G., Xing J., Xiao X., Liou A.K., Gao Y., Yin X.M., Clark R.S., Graham S.H., Chen J. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J. Neurosci. 2007, 27:9278-9293.
6. Croall D.E., Ersfeld K. The calpains: modular designs and functional diversity. Genome Biol. 2007, 8:218.
7. Dayton W.R. Comparison of low- and high-calcium-requiring forms of the calcium-activated protease with their autocatalytic breakdown products. Biochim. Biophys. Acta 1982, 709:166-172.
8. Dutt P., Croall D.E., Arthur S.C., De Veyra T., Williams K., Elce J.S., Greer P.A. m-Calpain is required for preimplantation embryonic development in mice. BMC Dev. Biol. 2006, 6:3.
9. Franco S.J., Huttenlocher A. Regulating cell migration: calpains make the cut. J. Cell Sci. 2005, 118:3829-3838.
10. Franco S., Perrin B., Huttenlocher A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp. Cell Res. 2004, 299:179-187.
11. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiol. Rev. 2003, 83:731-801.
12. Grynspan F., Griffin W.R., Cataldo A., Katayama S., Nixon R.A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 1997, 763:145-158.
13. Hamakubo T., Kannagi R., Murachi T., Matus A. Distribution of calpains I and II in rat brain. J. Neurosci. 1986, 6:3103-3111.
14. Konig N., Raynaud F., Feane H., Durand M., Mestre-Frances N., Rossel M., Ouali A., Benyamin Y. Calpain 3 is expressed in astrocytes of rat and Microcebus brain. J. Chem. Neuroanat. 2003, 25:129-136.
15. Li Y., Bondada V., Joshi A., Geddes J.W. Calpain 1 and Calpastatin expression is developmentally regulated in rat brain. Exp. Neurol. 2009, 220:316-319.
16. Ma H., Fukiage C., Kim Y.H., Duncan M.K., Reed N.A., Shih M., Azuma M., Shearer T.R. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization. J. Biol. Chem. 2001, 276:28525-28531.
17. Mathupala S.P. Delivery of small-interfering RNA (siRNA) to the brain. Expert Opin. Ther. Pat. 2009, 19:137-140.
18. Pardridge W.M. shRNA and siRNA delivery to the brain. Adv. Drug Deliv. Rev. 2007, 59:141-152.
19. Pfister E.L., Zamore P.D. Huntington's disease: silencing a brutal killer. Exp. Neurol. 2009, 220:226-229.
20. Roberts-Lewis J.M., Savage M.J., Marcy V.R., Pinsker L.R., Siman R. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 1994, 14:3934-3944.
21. Saatman K.E., Creed J., Raghupathi R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 2010, 7:31-42.
22. Shin S.J., Lee S.E., Boo J.H., Kim M., Yoon Y.D., Kim S.I., Mook-Jung I. Profiling proteins related to amyloid deposited brain of Tg2576 mice. Proteomics 2004, 4:3359-3368.
23. Siman R., Gall C., Perlmutter L.S., Christian C., Baudry M., Lynch G. Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res. 1985, 347:399-403.
24. Vosler P.S., Brennan C.S., Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol. Neurobiol. 2008, 38:78-100.
25. Waghray A., Wang D.S., McKinsey D., Hayes R.L., Wang K.K. Molecular cloning and characterization of rat and human calpain-5. Biochem. Biophys. Res. Commun. 2004, 324:46-51.
26. Wang K.K., Yuen P.W. Calpain substrates, assay methods, regulation, and its inhibitory agents. Pharmacology and Toxicology of Calcium-Depdendent Protease 1999, 77-101. Taylor and Francis, Philadelphia, PA. K.K. Wang, P.W. Yuen (Eds.).
27. Zadran S., Jourdi H., Rostamiani K., Qin Q., Bi X., Baudry M. Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J. Neurosci. 2010, 30:1086-1095.
28. Zhang W., Lane R.D., Mellgren R.L. The major calpain isozymes are long-lived proteins. Design of an antisense strategy for calpain depletion in cultured cells. J. Biol. Chem. 1996, 271:18825-18830.